JW Lifescience Statistics

Total Valuation

JW Lifescience has a market cap or net worth of KRW 176.37 billion. The enterprise value is 188.19 billion.

Market Cap	176.37B
Enterprise Value	188.19B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	Dec 27, 2024

Share Statistics

JW Lifescience has 15.48 million shares outstanding. The number of shares has decreased by -0.03% in one year.

Current Share Class	n/a
Shares Outstanding	15.48M
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	1.13%
Float	8.56M

Valuation Ratios

The trailing PE ratio is 6.63.

PE Ratio	6.63
Forward PE	n/a
PS Ratio	0.82
PB Ratio	1.08
P/TBV Ratio	n/a
P/FCF Ratio	10.74
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.76, with an EV/FCF ratio of 11.46.

EV / Earnings	7.07
EV / Sales	0.88
EV / EBITDA	3.76
EV / EBIT	5.47
EV / FCF	11.46

Financial Position

The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.28.

Current Ratio	1.87
Quick Ratio	1.43
Debt / Equity	0.28
Debt / EBITDA	0.99
Debt / FCF	2.82
Interest Coverage	13.65

Financial Efficiency

Return on equity (ROE) is 17.20% and return on invested capital (ROIC) is 9.54%.

Return on Equity (ROE)	17.20%
Return on Assets (ROA)	7.74%
Return on Capital (ROIC)	9.54%
Revenue Per Employee	712.66M
Profits Per Employee	88.40M
Employee Count	301
Asset Turnover	0.85
Inventory Turnover	6.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.85% in the last 52 weeks. The beta is 0.63, so JW Lifescience's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	-7.85%
50-Day Moving Average	11,070.40
200-Day Moving Average	11,925.00
Relative Strength Index (RSI)	60.01
Average Volume (20 Days)	32,392

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, JW Lifescience had revenue of KRW 214.51 billion and earned 26.61 billion in profits. Earnings per share was 1,718.00.

Revenue	214.51B
Gross Profit	54.09B
Operating Income	31.20B
Pretax Income	32.06B
Net Income	26.61B
EBITDA	46.87B
EBIT	31.20B
Earnings Per Share (EPS)	1,718.00

Full Income Statement

Balance Sheet

The company has 34.53 billion in cash and 46.36 billion in debt, giving a net cash position of -11.82 billion or -763.46 per share.

Cash & Cash Equivalents	34.53B
Total Debt	46.36B
Net Cash	-11.82B
Net Cash Per Share	-763.46
Equity (Book Value)	163.44B
Book Value Per Share	10,555.09
Working Capital	55.82B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 24.96 billion and capital expenditures -8.53 billion, giving a free cash flow of 16.43 billion.

Operating Cash Flow	24.96B
Capital Expenditures	-8.53B
Free Cash Flow	16.43B
FCF Per Share	1,060.97

Full Cash Flow Statement

Margins

Gross margin is 25.22%, with operating and profit margins of 14.54% and 12.40%.

Gross Margin	25.22%
Operating Margin	14.54%
Pretax Margin	14.94%
Profit Margin	12.40%
EBITDA Margin	21.85%
EBIT Margin	14.54%
FCF Margin	7.66%

Dividends & Yields

This stock pays an annual dividend of 500.00, which amounts to a dividend yield of 4.39%.

Dividend Per Share	500.00
Dividend Yield	4.39%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	29.10%
Buyback Yield	0.03%
Shareholder Yield	4.42%
Earnings Yield	15.08%
FCF Yield	9.31%

Dividend Details

Stock Splits

The last stock split was on April 20, 2018. It was a forward split with a ratio of 2.

Last Split Date	Apr 20, 2018
Split Type	Forward
Split Ratio	2

Scores

JW Lifescience has an Altman Z-Score of 3.26.

Altman Z-Score	3.26
Piotroski F-Score	n/a